Mounjaro®
Starting from £179.99/mo
Start journey Learn moreSemaglutide for weight management is taken once a week — the same day each week, by subcutaneous injection, as part of a gradual dose-escalation programme overseen by your prescriber. That weekly rhythm is fixed by the medicine's pharmacology, not by convenience. Understanding why semaglutide is taken at that frequency, and what happens if the timing slips, helps you get the most from treatment. These are prescription-only medicines, so the schedule your prescriber sets for you always takes precedence over general guidance.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Semaglutide has a long biological half-life of roughly one week, which is what makes a once-weekly injection workable. The drug accumulates to a steady level in the body over several weeks, and that stable plateau is what drives the sustained appetite reduction people notice on treatment. Injecting more frequently would push levels beyond the studied range; injecting less frequently would let them drop, reducing effect and disrupting the metabolic rhythm the medicine relies on.
The NHS medicines page for semaglutide confirms that the injection is given once weekly, on the same day each week if possible. You can shift that day if you need to (say, from Monday to Wednesday) but the gap between any two injections should be at least four days. A question our prescribers hear most weeks is how often you actually have to take semaglutide, including whether it is fine to take the injection a day early if the usual day falls on a holiday or a travel day. The short answer: a small shift of one or two days is acceptable, but the weekly pattern should be re-established afterwards rather than creeping forward each time.
Practically, many people pick a day that carries a small cue, a specific evening, a standing appointment, a weekly routine. That consistency matters more than which day you choose.
Taking semaglutide once a week throughout treatment does not mean taking the same dose every week from the start. Wegovy's licensed schedule begins at 0.25 mg and moves through 0.5 mg, 1.0 mg and 1.7 mg before reaching the standard 2.4 mg maintenance dose, with approximately four weeks at each level. A higher 7.2 mg maintenance dose was also approved by the MHRA in 2026 for eligible adults. Each step up is a clinical decision, not a patient preference, and your prescriber will review your progress, any side effects and your current weight before supporting a dose change.
The staging exists for a reason. Most of the nausea and digestive discomfort associated with semaglutide is worst in the early weeks at a new dose and tends to settle as the body adjusts. Moving through the schedule too quickly concentrates those side effects rather than distributing them across the titration. Wegovy's full prescribing journey is covered in more detail if you want to understand what each stage involves.
If you are considering the oral route, oral semaglutide tablets follow a different schedule altogether (once daily rather than once weekly) which is worth knowing before you compare the two formats.
This is the practical decision most people face at some point. The general principle (described in the Patient Information Leaflet and the NHS semaglutide guidance) is that a missed injection can be taken as soon as you remember, provided the next scheduled dose is still at least four days away. If the next dose is sooner than that, skip the missed one and carry on with the regular day. Never take two injections close together to make up for a missed dose.
For people who have been off semaglutide for more than a few weeks (for example, after a surgery, a supply gap, or a planned pause), the question of whether to restart at the current dose or step back to a lower one is genuinely important. Restarting at a high dose after a break can produce the same sharp side effects as a first escalation. That is a conversation for your prescriber, not a call to make based on what dose you were on before the gap.
You can read more about how often Wegovy is taken and what affects that rhythm, including practical tips for building the injection into a weekly routine. If questions about cost are part of how you are thinking about treatment, Wegovy pricing in the UK sets out what private prescriptions typically involve.
The once-weekly schedule is one of semaglutide's practical advantages: one injection a week is manageable for most people and does not require the daily routine adjustments that oral medications can demand. The titration period, typically around 16 to 20 weeks before reaching the 2.4 mg maintenance dose, is the phase that requires the most active engagement, both in terms of side-effect monitoring and in staying in contact with your clinical team.
Semaglutide is a prescription-only medicine. Eligibility is assessed by a prescriber who looks at your BMI, any weight-related health conditions, your current medication and your medical history. The licensed threshold for Wegovy injection is a BMI of 30 or above, or 27 or higher alongside at least one weight-related condition such as high blood pressure, high cholesterol or obstructive sleep apnoea. More on how semaglutide works covers the mechanism and the evidence in plain terms if that helps your thinking.
NICE's appraisal of semaglutide for weight management (TA875) covers the clinical evidence base in detail. At nume, every consultation is read by a GPhC-registered Independent Prescriber the same day, a real clinician assessing whether treatment is appropriate for you. If you are ready to take that step, check your eligibility with a free consultation.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.